Personalized serology, award-winning advice, and the latest product launches… Check out our highlights from ASMS 2022

2018 Power Lister, Emma Schymanski tells us about the growth of her research team and discusses the H2020 project ZeroPM and FAIR data exchange.

Advanced analytical technologies now offer the detailed assessments biopharma drug developers need.

Robbyn Anand, 2018 Power Lister, discusses her work over the past four years, and the pride she takes in teaching up-and-coming analytical scientists

How IC HRAM MS/MS can help us understand – and eventually forestall – lithium-ion battery degradation

Our annual Mass Spectrometry Supplement explores application notes from leading companies spanning the breadth of MS research

Tomas Cajka discusses his work at the Metabolomics Core Facility in Prague, a new LC-MS-based workflow, and novel metabolomics and lipidomics atlases

The potential of NMR for risk assessment and long-term monitoring of long COVID-19

Find out which sessions we’re particularly looking forward to in Minneapolis

Our microplastics problem is snowballing and we need standardized analytical techniques to dissect the issue